Tonghua Dongbao Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
Other companies in the rating peer group for Tonghua Dongbao Pharmaceutical Co Ltd are displayed below. The ESG rating covers seventeen UN SDGs including: 'Affordable & Clean Energy', 'Decent Work & Economic Growth' and 'Life below Water'. If you are employed by Tonghua Dongbao Pharmaceutical Co Ltd and you would like to licence your ESG aseessment, please contact us.
Tonghua Dongbao Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Tonghua Dongbao Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Tonghua Dongbao Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Tonghua Dongbao Pharmaceutical Co Ltd report the average age of the workforce?
Does Tonghua Dongbao Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Tonghua Dongbao Pharmaceutical Co Ltd offer flexible work?
Does Tonghua Dongbao Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Tonghua Dongbao Pharmaceutical Co Ltd conduct supply chain audits?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Tonghua Dongbao Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose water use targets?
Does Tonghua Dongbao Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Tonghua Dongbao Pharmaceutical Co Ltd have a product recall in the last two years?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Tonghua Dongbao Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Tonghua Dongbao Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose parental leave metrics?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Tonghua Dongbao Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Tonghua Dongbao Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Tonghua Dongbao Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose its waste policy?
Does Tonghua Dongbao Pharmaceutical Co Ltd report according to TCFD requirements?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose energy use targets?
Does Tonghua Dongbao Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Tonghua Dongbao Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Tonghua Dongbao Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.